Impact of the Cannabinoid System in Alzheimer's Disease

被引:10
作者
Li, Shuangtao [1 ]
Huang, Yuanbing [2 ]
Yu, Lijun [1 ]
Ji, Xiaoyu [2 ]
Wu, Jie [1 ,3 ]
机构
[1] Shantou Univ, Brain Funct & Dis Lab, Med Coll, 22 Rd Xinling, Shantou 515041, Guangdong, Peoples R China
[2] Yunfu Peoples Hosp, Dept Neurol, Yunfu 527300, Guangdong, Peoples R China
[3] Shantou Univ, Brain Funct & Dis Lab, Med Coll, Shantou, Peoples R China
基金
中国国家自然科学基金;
关键词
Cannabinoids; CB1; receptor; CB2; endocannabinoid; neurodegenerative diseases; Alzheimer's disease; TRANSGENIC MOUSE MODEL; DRIVEN RAT MODELS; CB2; RECEPTOR; AMYLOID-BETA; MESSENGER-RNA; HUMAN BRAIN; IN-VITRO; ENDOCANNABINOID SYSTEM; FUNCTIONAL EXPRESSION; COGNITIVE IMPAIRMENT;
D O I
10.2174/1570159X20666220201091006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoids are compounds isolated from cannabis and are also widely present in both nervous and immune systems of animals. In recent years, with in-depth research on cannabinoids, their clinical medicinal value has been evaluated, and many exciting achievements have been continuously accumulating, especially in the field of neurodegenerative disease. Alzheimer's disease is the most common type of neurodegenerative disease that causes dementia and has become a global health problem that seriously impacts human health today. In this review, we discuss the therapeutic potential of cannabinoids for the treatment of Alzheimer's disease. How cannabinoids act on different endocannabinoid receptor subtypes to regulate Alzheimer's disease and the roles of the endocannabinoid system in Alzheimer's disease are outlined, and the underlying mechanisms are discussed. Finally, we summarize the most relevant opportunities of cannabinoid pharmacology related to Alzheimer's disease and discuss the potential usefulness of cannabinoids in the clinical treatment of Alzheimer's disease.
引用
收藏
页码:715 / 726
页数:12
相关论文
共 176 条
[21]  
2-7
[22]   Biphasic effects of THC in memory and cognition [J].
Calabrese, Edward J. ;
Rubio-Casillas, Alberto .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (05)
[23]   Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum [J].
Campion, D ;
Dumanchin, C ;
Hannequin, D ;
Dubois, B ;
Belliard, S ;
Puel, M ;
Thomas-Anterion, C ;
Michon, A ;
Martin, C ;
Charbonnier, F ;
Raux, G ;
Camuzat, A ;
Penet, C ;
Mesnage, V ;
Martinez, M ;
Clerget-Darpoux, F ;
Brice, A ;
Frebourg, T .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :664-670
[24]   The Potential Therapeutic Effects of THC on Alzheimer's Disease [J].
Cao, Chuanhai ;
Li, Yaqiong ;
Liu, Hui ;
Bai, Ge ;
Mayl, Jonathan ;
Lin, Xiaoyang ;
Sutherland, Kyle ;
Nabar, Neel ;
Cai, Jianfeng .
JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (03) :973-984
[25]   Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy [J].
Casarejos, Maria J. ;
Perucho, Juan ;
Gomez, Ana ;
Munoz, Maria P. ;
Fernandez-Estevez, Marian ;
Sagredo, Onintza ;
Fernandez Ruiz, Javier ;
Guzman, Manuel ;
Garcia de Yebenes, Justo ;
Mena, Maria A. .
JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (03) :525-539
[26]   From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases [J].
Cassano, Tommaso ;
Villani, Rosanna ;
Pace, Lorenzo ;
Carbone, Antonio ;
Bukke, Vidyasagar Naik ;
Orkisz, Stanislaw ;
Avolio, Carlo ;
Serviddio, Gaetano .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[27]   Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease [J].
Ceccarini, Jenny ;
Casteels, Cindy ;
Ahmad, Rawaha ;
Crabbe, Melissa ;
Van de Vliet, Laura ;
Vanhaute, Heleen ;
Vandenbulcke, Mathieu ;
Vandenberghe, Wim ;
Van Laere, Koen .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (11) :2348-2357
[28]   Brain cannabinoid receptor 2: expression, function and modulation [J].
Chen, De-Jie ;
Gao, Ming ;
Gao, Fen-Fei ;
Su, Quan-Xi ;
Wu, Jie .
ACTA PHARMACOLOGICA SINICA, 2017, 38 (03) :312-316
[29]   Role of Mitochondrial Amyloid-β in Alzheimer's Disease [J].
Chen, John Xi ;
Yan, Shirley Shidu .
JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 :S569-S578
[30]   Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling [J].
Chen, Rongqing ;
Zhang, Jian ;
Fan, Ni ;
Teng, Zhao-qian ;
Wu, Yan ;
Yang, Hongwei ;
Tang, Ya-ping ;
Sun, Hao ;
Song, Yunping ;
Chen, Chu .
CELL, 2013, 155 (05) :1154-1165